Teradyne, Inc. director Mercedes Johnson filed a Form 144 notice of proposed sale of 166 shares of Teradyne common stock, dated November 2, 2026, through Fidelity Brokerage Services LLC on NASDAQ.

Key Highlights

  • Proposed sale: Mercedes Johnson, a director of Teradyne, Inc., intends to sell 166 shares of common stock with an aggregate market value of $45,723.04.
  • Shares outstanding: According to the filing, 156,124,751 shares of Teradyne common stock were outstanding at the time of notice.
  • Acquisition origin: The 166 shares were acquired on May 10, 2016, through restricted stock vesting from the issuer, with compensation listed as the nature of payment.
  • 10b5-1 plan: The filing indicates a Rule 10b5-1 trading plan adoption date of March 4, 2026.
  • Prior sales: Johnson sold 166 shares on August 3, 2026 (gross proceeds $59,452.90), 167 shares on September 1, 2026 (gross proceeds $56,997.10), and 167 shares on October 1, 2026 (gross proceeds $67,284.30) in the past three months.
  • Approximate sale date: The proposed sale is scheduled for approximately November 2, 2026.

Teradyne Director Mercedes Johnson Files Notice of Proposed Share Sale

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Mercedes Johnson, a director of Teradyne, Inc. (NASDAQ:TER), has given notice of a proposed sale of 166 shares of the company's common stock. The filing states the aggregate market value of those shares is $45,723.04, with the approximate date of sale listed as November 2, 2026. The broker named in the filing is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island.

The filing discloses that the 166 shares subject to the proposed sale were acquired on May 10, 2016, through a restricted stock vesting transaction from the issuer, with the nature of payment recorded as compensation. The filing also notes that a Rule 10b5-1 trading plan was adopted on March 4, 2026, under which the sale is being made. The notice was signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Mercedes Johnson.

The filing reports three prior sales in the past three months by Johnson: 166 shares sold on August 3, 2026, generating gross proceeds of $59,452.90; 167 shares sold on September 1, 2026, generating gross proceeds of $56,997.10; and 167 shares sold on October 1, 2026, generating gross proceeds of $67,284.30. All sales were of Teradyne common stock. The filing states that 156,124,751 shares of Teradyne common stock were outstanding at the time of the notice.

What Was Disclosed

Teradyne director Mercedes Johnson filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 166 shares of Teradyne common stock with an aggregate market value of $45,723.04, to be executed under a Rule 10b5-1 plan adopted March 4, 2026.